Jindal Drugs Pvt Ltd
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE 6.84 %
- ROE 5.82 %
- Face Value ₹ 10.0
Pros
Cons
- Earnings include an other income of Rs.45.1 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | |
|---|---|---|
| 940 | 873 | |
| 802 | 821 | |
| Operating Profit | 138 | 52 |
| OPM % | 15% | 6% |
| 21 | 45 | |
| Interest | 21 | 6 |
| Depreciation | 18 | 25 |
| Profit before tax | 120 | 66 |
| Tax % | 21% | 20% |
| 95 | 53 | |
| EPS in Rs | ||
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | |
|---|---|---|
| Equity Capital | 112 | 132 |
| Reserves | 757 | 809 |
| 155 | 143 | |
| 71 | 64 | |
| Total Liabilities | 1,095 | 1,148 |
| 171 | 253 | |
| CWIP | 89 | 6 |
| Investments | 333 | 367 |
| 501 | 522 | |
| Total Assets | 1,095 | 1,148 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | |
|---|---|---|
| 120 | 66 | |
| 0 | 0 | |
| 0 | 0 | |
| Net Cash Flow | 120 | 66 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | |
|---|---|---|
| Debtor Days | 37 | 42 |
| Inventory Days | 67 | 98 |
| Days Payable | 16 | 7 |
| Cash Conversion Cycle | 87 | 133 |
| Working Capital Days | 117 | 162 |
| ROCE % | 7% |
Documents
Announcements
No data available.
Annual reports
No data available.